- IOL Chemicals & Pharmaceuticals posted record Q1FY27 performance, with PAT rising 90% to Rs.64.05 cr. Non-Ibuprofen products contributed 43% of pharma revenue, while chemicals revenue and EBIT grew 29% and 193% YoY, respectively. Stock may surpass its 52-week high of Rs.180.
- Jyoti posted Q1FY27 PAT of Rs.5.15 cr. against Rs.3.26 cr. in Q4FY26, a 58% QoQ jump. With a PE of just 7x, the stock looks attractive v/s lifetime high of Rs.208.
- Morepenlab posted its highest-ever quarterly revenue and earnings, with EBITDA and PAT growing 207% and 394%, respectively. Strong API recovery, exports and medical devices growth support the outlook. Stock looks attractive at Rs.84 v/s lifetime high of Rs.222.
- Sarla Performance Fibers posted Q1FY27 PBT of Rs.46.30 cr. against Rs.5.47 cr. in Q4FY26, a 746% QoQ jump, with FY27 EPS potentially exceeding Rs.21. Promoter holding rose to 59.98% from 57.11%. Paid 200% dividend for FY26. Stock looks attractive and may surpass Rs.132.
- Super Crop Safe posted 162% higher PAT in Q1FY27 on income of Rs.18.56 cr. Stock looks attractive at CMP v/s lifetime high of Rs.37.75.
- Smruthi Organics turned profitable with Q1FY27 PAT of Rs.2.88 cr. against a loss of Rs.1.10 cr. in Q1FY26. Q1 EPS of Rs.2.57 could lead to FY27 EPS of Rs.12+. Paid 15% dividend for FY26. Stock looks attractive v/s lifetime high of Rs.419.
